1
Levodopa Benserazide Generic Formulation Versus the Originator
Condition(s):Parkinson DiseaseLast Updated:April 18, 2016Completed
Levodopa: 711 Clinical Trials, Page 1 of 72
Hide Studies Not Open or Pending
2
Study on Tolerability of Levodopa/Carbidopa in Children With Angelman Syndrome
Condition(s):Angelman SyndromeLast Updated:November 21, 2016Completed
3
Levodopa Response and Gut Microbiome in Patients With Parkinson’s Disease
Condition(s):Parkinson DiseaseLast Updated:July 9, 2021Completed
4
A Single Period Investigation to Assess the Tolerability of Healthy Subjects to Oral Sinemet® (Levodopa/Carbidopa)
Condition(s):Parkinson’s DiseaseLast Updated:July 1, 2015Completed
5
Fasting Comparative Bioavailability of Two Tablet Formulations of Levodopa /Benserazide in Healthy Volunteers
Condition(s):Healthy VolunteersLast Updated:August 4, 2011Completed
6
A Trial of Levodopa in Angelman Syndrome
Condition(s):Angelman SyndromeLast Updated:July 15, 2020Completed
7
A Study to Assess the Effect of Safinamide on Levodopa Pharmacokinetics
Condition(s):Idiopathic Parkinson’s DiseaseLast Updated:March 29, 2013Completed
8
Efficacy of Levodopa/Benserazide Dispersible Tablet on Response Fluctuations in PD Patients With Delayed ON
Condition(s):Parkinson DiseaseLast Updated:May 7, 2021Completed
9
eArly levoDopa With Opicapone in Parkinson’s paTients wIth motOr fluctuatioNs.
Condition(s):Parkinson DiseaseLast Updated:October 14, 2021Not yet recruiting
10
Assessing the Pharmacokinetics, Safety, Tolerability and Efficacy of Continuous Oral Levodopa Via the DopaFuse® Delivery System in Parkinson’s Disease Patients
Condition(s):Parkinson’s DiseaseLast Updated:July 27, 2021Recruiting